Skip to main content
. 2014 Oct 1;349:g5459. doi: 10.1136/bmj.g5459

Table 3.

Cost effectiveness analysis summary

Study Currency, year Perspective Effect ΔC* ΔE Exact ICER*
Detemir versus NPH
Valentine,54 2012 Euro, 2010 Public healthcare payer, Denmark QALY 68.35 0.02 3418
Euro, 2010 Public healthcare payer, Sweden QALY 69.09 0.02 3455
Euro, 2010 Public healthcare payer, Finland QALY 88.04 0.02 4402
Euro, 2010 Healthcare payer, Netherlands QALY 63.24 0.02 3162
Valentine,55 2011 Swedish Krnor, 2006 Public healthcare payer QALY 4329.38 0.53 8169
Swedish Krnor, 2006 Public healthcare payer Life years 4329.38 0.14 30 924†
Cameron,5 2009 Canadian, 2007 Public healthcare payer QALY 3718.61 0.01 371 861
Gschwend,57 2009 Euro, 2006 Third party payer, Belgium QALY −18 300.85 0.52 −35 194
Euro, 2006 Third party payer, France QALY 435.22 0.55 791
Euro, 2006 Third party payer, Germany QALY −1308.74 0.45 −2908
Euro, 2006 Third party payer, Italy QALY 2907.11 0.59 4927
Euro, 2006 Third party payer, Spain QALY −882.71 0.40 −2207
Tunis,58 2009 Canadian dollars, 2007 Public healthcare payer QALY 9935.13 0.48 20 698
Canadian dollars, 2007 Public healthcare payer Life years 9935.13 0.05 198 703†
Glargine versus NPH
Pfohl,53 2012 Euro, 2010 Public healthcare payer QALY −14 823 188.10 793 −18 693
Euro, 2010 Public healthcare payer Life years −14 823 188.10 392 −37 914†
Cameron,5 2009 Canadian dollars, 2007 Public healthcare payer QALY 2930.21 0.04 73255
Greiner,56 2009‡ CHF, 2006 NR QALY 1437.71 0.24 5990
CHF, 2006 NR Life years 1437.71 0.06 23 962
Grima,59 2007 Canadian dollars, 2005 Public healthcare payer QALY 1426.06 0.07 20 372
Canadian dollars, 2005 Public healthcare payer Life years 1426.06 0.08 17 826†
McEwan,60 2007 UK pounds, 2005 Public healthcare payer 2534.14 0.13 19 493
Glargine versus detemir
Valentine,61 2006 US dollars, 2005 Societal QALY 6563.69 −0.06 −109 395
US dollars, 2005 Societal Life years 6563.69 −0.09 −72 930†

ΔC=difference in cost between treatment and control; ΔE=difference in effectiveness between treatment and control; ICER=incremental cost effectiveness ratio; NPH=neutral protamine Hagedorn; NR=not reported; QALY=quality adjusted life years.

*In US dollars, 2012.

†ICER was derived.

‡Unpublished data.